Search Results - "HENSS, H"

Refine Results
  1. 1

    Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer by HARDER, J, RIECKEN, B, KUMMER, O, LOHRMANN, C, OTTO, F, USADEL, H, GEISSLER, M, OPITZ, O, HENSS, H

    Published in British journal of cancer (09-10-2006)
    “…This phase II study was conducted to determine the efficacy and toxicity of a gemcitabine (GEM) and oxaliplatin (OX) chemotherapy protocol in patients with…”
    Get full text
    Journal Article
  2. 2

    Supportive Maßnahmen der Komplementärmedizin by Henß, H., Münstedt, K., Jückstock, J., Reinert, E., Hübner, J.

    Published in Der Onkologe (01-08-2010)
    “…Zusammenfassung Bei der Symptomkontrolle im Rahmen maligner Erkrankungen können auch komplementäre Verfahren bedeutende Beiträge liefern. Dies wird am Beispiel…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Preclinical phase II study of ifosfamide in human tumour xenografts in vivo by Berger, D P, Fiebig, H H, Winterhalter, B R, Wallbrecher, E, Henss, H

    “…The in vivo effects of the oxazaphosphorine compound ifosfamide (IFO) on human tumour xenografts were assessed in thymus aplastic nude mice. The human origin…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The clonogenic assay with human tumor xenografts: evaluation, predictive value and application for drug screening by Berger, D P, Henss, H, Winterhalter, B R, Fiebig, H H

    Published in Annals of oncology (01-09-1990)
    “…The feasibility, evaluation and predictive value of the colony-forming assay with human tumor xenografts for screening anticancer drugs have been studied…”
    Get more information
    Journal Article
  7. 7

    Development of three human small cell lung cancer models in nude mice by Fiebig, H H, Neumann, H A, Henss, H, Koch, H, Kaiser, D, Arnold, H

    Published in Recent results in cancer research (1985)
    “…The transplantation of seven human small cell lung cancers (SCLC) into athymic nude mice resulted in the development of three tumor lines that are suitable for…”
    Get more information
    Journal Article
  8. 8

    Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura by Henss, H, Fiebig, H H, Schildge, J, Arnold, H, Hasse, J

    Published in Onkologie (01-06-1988)
    “…The effectiveness of combination chemotherapy with doxorubicin and cisplatin was studied in patients with advanced malignant pleuramesothelioma. 19 patients…”
    Get more information
    Journal Article
  9. 9

    Outpatient chemotherapy with gemcitabine and oxaliplatin in advanced biliary tract cancer; a phase II study by Harder, J., Riecken, B., Kummer, O., Lohrmann, C., Geissler, M., Otto, F., Opitz, O., Henss, H.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 14006 Background: Biliary tract cancer is a heterogeneous tumor entity with a poor prognosis if unresectable. There is a need for an effective,…”
    Get full text
    Journal Article
  10. 10

    Comparison of tumor response in nude mice and in the patients by Fiebig, H H, Schuchhardt, C, Henss, H, Fiedler, L, Löhr, G W

    Published in Behring Institute Mitteilungen (01-05-1984)
    “…In 34 tumors of different origin 50 comparisons between the tumor response in the patients and in nude mice were performed. Combination chemotherapy was more…”
    Get more information
    Journal Article
  11. 11

    Clonal growth of human tumor xenografts. First experiences in drug testing by Henss, H, Fiebig, H H, Meinhardt, K, Löhr, G W

    “…Human tumors growing as nude mice xenografts were investigated for growth in a clonogenic assay. Colony formation of more than 30 colonies per plate was…”
    Get full text
    Journal Article
  12. 12

    5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)" by Flechtner, H, Queisser, W, Heim, M E, Henss, H, Arnold, H, Fritze, D, Herrmann, R, Fritsch, H, Fritz, M, Trux, F A

    Published in Onkologie (01-04-1987)
    “…In a phase-II-trial 40 patients with advanced gastric cancer were treated with 5-fluorouracil, 4-epidoxorubicin, mitomycin C (FEM) combination therapy…”
    Get more information
    Journal Article
  13. 13

    Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development by Fiebig, H H, Schmid, J R, Bieser, W, Henss, H, Lohr, G W

    “…The colony formation of human tumor xenografts from nude mice, of murine tumors, and of human bone marrow (CFU-C) has been investigated in vitro using a…”
    Get more information
    Journal Article
  14. 14

    Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer by Schnitzler, G, Queisser, W, Heim, M E, König, H, Katz, R, Fritze, D, Herrmann, R, Arnold, H, Henss, H, Trux, F A

    Published in Cancer treatment reports (01-04-1986)
    “…Seventy-seven patients with advanced gastric carcinoma were prospectively randomized to receive 5-FU and carmustine (FB) with or without doxorubicin (FAB)…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Correlation of drug response in patients and in the clonogenic assay with solid human tumour xenografts by Scholz, C C, Berger, D P, Winterhalter, B R, Henss, H, Fiebig, H H

    Published in European journal of cancer (1990) (1990)
    “…The potential of evaluating the preclinical response of solid tumours was studied in human tumour xenografts in the clonogenic assay. Tumour specimens…”
    Get more information
    Journal Article
  17. 17

    Prognostic factors in diffuse malignant mesothelioma of the pleura by Schildge, J, Kaiser, D, Henss, H, Fiebig, H, Ortlieb, H

    Published in Pneumologie (Stuttgart, Germany) (01-11-1989)
    “…Diffuse malignant pleural mesothelioma (DMM) is associated with a very poor prognosis and is only partially accessible to treatment. On the basis of a…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20